In this episode, we break down Nvidia's strategic move of injecting $50 million into Recursion's AI drug discovery initiatives, analyzing the motives behind this substantial investment and its potential to reshape the healthcare landscape.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
AI Breakdown